BioSpace News Archive

Windtree Therapeutics, Inc. (NasdaqCM: WINT), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases, today announced that all initial European trial sites are active and enrolling or able to enroll patients into i

-Immunomic to invest in Replicate’s seed round; funding will enable Replicate to accelerate self-replicating RNA technology and grow operations-

-SFA Therapeutics receives award from Ben Franklin Technology Partners- -Melior Discovery selected as partner-

AllerGenis LLC, a data-driven precision diagnostics company focused on food allergies, today announced the onset of operations at its Hatfield facility to test patient samples using its VeriMAP TM Peanut Diagnostic, a diagnostic solution for patients with peanut allergies. AllerGenis received full certification under Clinical Laboratory Improvement Amendments of 1988 (CLIA) to perform its high complexity clinical l

Lineage Cell Therapeutics to Present OpRegen ® Data at International Society for Stem Cell Research (ISSCR) 2020 Virtual Annual Meeting

Novan, Inc. (“the Company” or “Novan”) (Nasdaq:NOVN) today announced that Paula Brown Stafford, the Company’s President and Chief Executive Officer, will present a corporate overview at the Life Sciences Investor Forum on Thursday, June 25, 2020 at 2:00 p.m. Eastern. This will be a live, interactive online event where investors are invited to ask the company questions in real-time. The presentation and Q&A session will be webcast live

For over a decade, La Roche-Posay has led the fight to stop skin cancer with their SOS - Save Our Skin program, dedicated to educating the public about sun safe practices

Alpine Immune Sciences, Inc. (NASDAQ:ALPN), a leading clinical-stage immunotherapy company focused on developing innovative treatments for cancer and autoimmune/inflammatory diseases, today announced that the first patient has been successfully dosed in its NEON-1 Phase 1 study of ALPN‑202, a first-in-class conditional CD28 costimul

RemedyOne, a formulary optimization company focused on making systems work, is leading the charge to increase member access to prescription digital therapeutics (PDTs) to help fight the current public health crises of substance use disorder (SUD) and opioid use disorder (OUD) as people are impacted by COVID-19 and social distancing reSET and reSET-O will be made available as a covered benefit to RemedyOne’s customer base of 2.5 million lives

Sensus Healthcare, Inc. (Nasdaq: SRTS ), a medical device company specializing in highly effective, non-invasive treatments for both oncological and non-oncological conditions, announces that Jeffrey S. Fromowitz, M.D. will discuss the use of superficial radiation therapy at the Fall Clinical Virtual Grand Rounds Weekly Continuing Education Series today. The presentation is part of the recent online series titled “ Evolving Concepts in Dermat